← SynDRA
UBP-302
SynDRA canonical compound SYN0359609 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GRIK1 |
|---|
| Mechanism of action | Glutamate receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Glutamate receptor antagonist
- GRIK1 ANTAGONIST
- GRIK1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:447996
- UBP302
- Tocris-2079
- FZ8AP4UA5Y
- UBC
- GTPL4333
- orb1706497
- SCHEMBL2265710
- SCHEMBL29651286
- UBP 296
- 2f35
- HMS3413E11
- HMS3677E11
- BDBM50178136
- HB0627
- MFCD06411607
- AKOS024456932
- NCGC00025352-01
- DA-78742
- FU161075
- MS-25018
- UBP302, >=98% (HPLC)
- HY-107604
- CS-0028945
- SR-01000597533
- SR-01000597533-1
- BRD-K79753741-001-01-7
- NCGC00025351-01
- Tocris-2078
- BDBM50178137
- SR-01000597532-1
- HY-107605
- BDBM50178148
- BRD-A45499626-001-03-6
- AKOS024456931
- SR-01000597532
- DA-68450
- 2-[[3-(2-amino-2-carboxyethyl)-2,6-dioxo-1-pyrimidinyl]methyl]benzoic acid
- CHEBI:91719
Look up UBP-302 in the interactive SynDRA portal →